Yew Bio-Pharm Group, Inc.
YEWB · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,465 | $986 | -$1,322 | $3,213 |
| Dep. & Amort. | $2,817 | $1,827 | $11,042 | $3,747 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $284 | $1,068 | $709 |
| Change in WC | $2,291 | $2,742 | $12,822 | -$10,289 |
| Other Non-Cash | $10,767 | $6,115 | $8,858 | -$10 |
| Operating Cash Flow | $17,340 | $11,954 | $32,467 | -$2,620 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$17,356 | -$14,682 | -$32,800 | -$799 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$17 | $13 | -$33 | -$1 |
| Investing Cash Flow | -$17,356 | -$14,669 | -$32,800 | -$799 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$14 | $2,905 | $26 | $3,925 |
| Financing Cash Flow | -$14 | $2,905 | $26 | $3,925 |
| Forex Effect | -$148 | $31 | -$31 | $75 |
| Net Chg. in Cash | -$179 | $221 | -$338 | $581 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $742 | $522 | $860 | $279 |
| End Cash | $564 | $742 | $522 | $860 |
| Free Cash Flow | -$16 | -$2,728 | -$333 | -$3,419 |